Benefits

Dashboard

See Price & Plans

Not registered yet? Get a free account.

Suven Pharmaceuticals Limited
Location
T. Score
Financials
- Financial Highlights
- Balance Sheet
- Profit & Loss
- Ratios
Charges
People
Network
Registered Details

SUVEN PHARMACEUTICALS LIMITED

Active

Updated: 17 Mar 2024

Suven Pharmaceuticals Limited, is an unlisted public company incorporated on 06 November, 2018. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 40.00 cr and the total paid-up capital is INR 25.46 cr.

Suven Pharmaceuticals Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 0.53% over the previous year. At the same time, it's book networth has increased by 15.04%.

Industry

Manufacturing of Pharmaceuticals

Products

Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Total Revenue

-8.84%

₹ GET PRO

EBITDA

0.53%

₹ GET PRO

Net Profit

-22.49%

₹ GET PRO

Networth

15.04%

₹ GET PRO

Borrowings

-27.63%

₹ GET PRO

Assets

8.5%

₹ GET PRO

Gross Margin

0.13

GET PRO %

Operating Margin

-0.09

GET PRO %

Net Profit Margin

-5.54

GET PRO %

Return on Equity

-11.97

GET PRO %

ROCE

-0.38

GET PRO %

Debt to Equity

-0.02

GET PRO

Sales

Mar 2023

Net worth

Mar 2023

Buy Report or Plans

Dashboards

Popular Plan

Company dashboard

₹ 449
- Five year financials and ratios
- Risk analysis
- Interactive charts

View subscriptions and buy credits

MCA Fillings

All financials

₹ 349
- All financials
- All annual returns
- MoA and AoA
1 Year

₹ 249
- Latest financials
- Latest annual return
- MoA and AoA

PDF Reports

Financial report

₹ 799
- Five year financials and ratios
- Shareholding and group structure
- Litigation and more
Due diligence report

₹ 2999
- Everything in financial report
- Peers and financials

* GST not included

** Reports & MCA filings will be based on the latest available financials.

Locations

India (8)

State	Type	Address

Locations on Map

Tofler Score

Poor

Fair

Good

Very Good

Excellent

Risk

Severe Risk

No risks identified

Moderate Risk

No risks identified

Low Risk

No risks identified

About Tofler Score

Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Financial Highlights

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Gross margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Networth
Borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Debt to equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ROE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
WC days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Margins

Gross margin

Operating margin

Net margin

Balance Sheet

Standalone

Consolidated

₹

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Percentage of assets	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Reserves	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Borrowings +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Long term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Short term borrowings	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade payables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other liabilities +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total liabilities	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
CWIP	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Intangible assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
LT loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other non-current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Current assets +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Inventories	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Trade receivables	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cash and cash equivalents	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
ST loans and advances	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other current assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	12.7	12.7	25.5	25.5	25.5
Reserves	577.6	832.0	1,155.4	1,501.7	1,709.7
Borrowings +	82.8	185.3	141.2	95.6	69.2
Long term borrowings	-	91.3	35.6	28.4	4.6
Short term borrowings	82.8	94.0	105.6	67.1	64.6
Trade payables +	53.6	71.1	82.9	105.9	65.2
Days payable	189.0	113.0	100.0	97.0	58.0
Other liabilities +	109.9	142.8	152.4	206.8	161.4
Other non-current liabilities	35.1	36.4	38.3	63.7	67.2
Other current liabilities	21.2	35.3	31.2	37.3	29.0
Total liabilities	783.0	1,172.8	1,474.5	1,829.6	1,965.7
Fixed Assets +	382.0	457.6	537.5	564.2	828.4
Tangible assets	268.2	353.1	438.7	532.0	601.1
CWIP	111.1	101.7	96.3	30.0	165.1
Intangible assets	2.7	2.8	2.4	2.2	62.2
LT loans and advances	-	-	-	-	-
Other non-current assets	11.2	323.5	372.1	137.4	126.3
Current assets +	389.7	391.6	564.8	1,127.9	1,011.0
Inventories	157.1	174.9	201.1	283.4	312.8
Trade receivables	147.5	117.2	102.4	236.4	110.9
Cash and cash equivalents	10.9	11.7	7.2	44.6	64.8
ST loans and advances	0.1	0.2	0.2	0.2	0.2
Other current assets	74.1	87.7	253.9	563.4	522.3
Total assets	783.0	1,172.8	1,474.5	1,829.6	1,965.7

Percentage of assets	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Equity Capital	1.63	1.09	1.73	1.39	1.3
Reserves	73.76	70.94	78.36	82.08	86.98
Borrowings +	10.57	15.8	9.58	5.22	3.52
Long term borrowings	0.0	7.78	2.41	1.55	0.23
Short term borrowings	10.57	8.02	7.16	3.67	3.29
Trade payables	6.84	6.06	5.62	5.79	3.31
Other liabilities +	14.04	12.17	10.34	11.3	8.21
Other non-current liabilities	4.48	3.11	2.6	3.48	3.42
Other current liabilities	2.71	3.01	2.11	2.04	1.48
Total liabilities
Fixed Assets +	48.78	39.01	36.45	30.84	42.14
Tangible assets	34.25	30.1	29.76	29.08	30.58
CWIP	14.18	8.67	6.53	1.64	8.4
Intangible assets	0.34	0.24	0.16	0.12	3.16
LT loans and advances	0.01	0.01	0.0	0.0	0.0
Other non-current assets	1.44	27.59	25.24	7.51	6.42
Current assets +	49.77	33.39	38.3	61.65	51.43
Inventories	20.06	14.91	13.64	15.49	15.91
Trade receivables	18.84	9.99	6.94	12.92	5.64
Cash and cash equivalents	1.39	1.0	0.49	2.44	3.3
ST loans and advances	0.01	0.02	0.01	0.01	0.01
Other current assets	9.47	7.48	17.22	30.79	26.57
Total assets

Total assets

Profit & Loss

Standalone

Consolidated

₹

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Sales growth %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net margin %	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

Precentage of total income	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Expenses +	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Cost of goods	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Employee cost	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other costs	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Other income	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Depreciation	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Exceptional items	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit before tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Tax	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Profit - disc. ops	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net profit	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales +	377.8	833.8	1,009.7	1,320.2	1,340.3
Sales growth %	None	120.68	21.1	30.75	1.52
Expenses +	220.6	495.6	610.0	786.1	827.0
Cost of goods	103.2	229.2	301.9	399.1	409.1
Employee cost	29.6	73.7	76.2	100.5	110.5
Other costs	73.5	145.8	191.1	241.2	254.1
Operating profit +	171.6	385.1	440.5	579.4	566.5
Operating margin %	45.4	46.2	43.6	43.9	42.3
Other income	0.6	18.1	14.2	92.4	46.4
Interest	2.8	23.1	9.1	6.2	5.4
Depreciation	11.5	23.9	31.6	39.1	47.7
Exceptional items	-	-	-	-	-
Profit before tax	157.9	356.3	413.9	626.5	559.7
Tax	48.6	87.5	105.3	213.8	148.4
Profit - disc. ops	-	-	-	-	-
Net profit	109.3	317.0	362.3	453.8	411.3
Net margin %	28.9	37.2	35.4	32.1	29.7

Precentage of total income	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Sales	99.84	97.87	98.61	93.46	96.66
Expenses +	58.28	58.18	59.57	55.65	59.64
Cost of goods	27.27	26.9	29.49	28.25	29.5
Employee cost	7.83	8.65	7.44	7.11	7.97
Other costs	19.41	17.11	18.66	17.08	18.33
Operating profit	45.33	45.21	43.02	41.02	40.86
Other income	0.16	2.13	1.39	6.54	3.34
Interest	0.74	2.71	0.89	0.44	0.39
Depreciation	3.04	2.8	3.09	2.77	3.44
Exceptional items	0.0	0.0	0.0	0.0	0.0
Profit before tax	41.72	41.82	40.43	44.35	40.36
Tax	12.84	10.27	10.29	15.13	10.7
Profit - disc. ops	0.0	0.0	0.0	0.0	0.0
Net profit	28.88	37.21	35.39	32.13	29.66

Revenue from operations

Ratios

Standalone

Consolidated

Financials upto March 2023 available in Tofler Pro

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Solvency +
Total Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Debt/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Debt/Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Assets/Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Liquidity +
Current Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Quick Ratio	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Interest Coverage	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Performance
Gross Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Operating Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Net Margin	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return +
Return on Equity	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROCE	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Return on Assets	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Pre-tax ROIC	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Efficiency +
Days Payable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Inventory	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Days Receivable	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Fixed Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Total Asset Turnover	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital
Cash Conversion Cycle	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO
Working Capital Days	GET PRO	GET PRO	GET PRO	GET PRO	GET PRO

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Solvency +
Total Debt/Equity	0.1	0.2	0.1	0.1	0.0
Net Debt/Equity	0.1	0.2	0.1	0.0	0.0
Total Debt/Assets	0.1	0.2	0.1	0.1	0.0
Total Assets/Equity	1.3	1.4	1.2	1.2	1.1
Liquidity +
Current Ratio	2.5	1.9	2.6	5.4	6.4
Quick Ratio	1.5	1.1	1.7	4.0	4.4
Interest Coverage	61.5	16.7	48.2	93.0	104.2
Performance
Gross Margin	72.7	72.5	70.1	69.8	69.5
Operating Margin	45.4	46.2	43.6	43.9	42.3
Net Margin	28.9	37.2	35.4	32.1	29.7
Return +
Return on Equity	18.5	37.5	30.7	29.7	23.7
Pre-tax ROCE	26.1	55.7	46.3	36.5	30.9
Return on Assets	14.0	27.0	24.6	24.8	20.9
Pre-tax ROIC	24.2	35.5	31.1	34.2	29.8
Efficiency +
Days Payable	189.0	113.0	100.0	97.0	58.0
Days Inventory	556.0	278.0	243.0	259.0	279.0
Days Receivable	142.0	51.0	37.0	65.0	30.0
Fixed Asset Turnover	1.0	1.8	1.9	2.3	1.6
Total Asset Turnover	0.5	0.7	0.7	0.7	0.7
Working Capital
Cash Conversion Cycle	509.0	216.0	180.0	227.0	251.0
Working Capital Days	224.0	84.0	125.0	254.0	232.0

Ratios

Current ratio

Debt/equity ratio

Charges on assets

Bank wise

Charges

State Bank of India

No. of Loans: 1

Total Amount : 67.0 cr

BANK OF BAHRAIN AND KUWAIT BSC

No. of Loans: 1

Total Amount : 10.0 cr

Charge Holder	Amount	Date of creation/modification
State Bank of India	67.0 cr	24 Jul, 2023
BANK OF BAHRAIN AND KUWAIT BSC	10.0 cr	29 Dec, 2020

Charges

State Bank of India

BANK OF BAHRAIN AND KUWAIT BSC

People

Designation	Name	DIN/PAN	Tenure
Director	Kumarapuram Gopalakrishnan Ananthakrishnan	00019325	2 years
Director	Shweta Jalan	00291675	2 years
Director	Annaswamy Vaidheesh	01444303	2 years
Director	Matangi Gowrishankar	01518137	2 years
Director	Vinod Rao	01788921	2 years
Kmp	Sudhir Kumar Singh	<HIDDEN>	2 years
Kmp	Himanshu Agarwal	<HIDDEN>	1 years
Director	Pravin Udhyavara Bhadya Rao	06782450	2 years
Director	Venkatanaga Kali Vara Prasada Raju Vetukuri	07267366	2 years
Director	Pankaj Patwari	08206620	2 years
CS	Hanumantha Rao Kokkonda	<HIDDEN>	5 years

Company Network

Companies connected through Directors

Name	Status	Paid up Capital	Common Directors	Address
SAPALA ORGANICS PRIVATE LIMITED	Active	12.5 Cr	2	Telangana
YES BANK LIMITED	Active	6,269.4 Cr	1	Maharashtra
COHANCE LIFESCIENCES LIMITED	Active	3,394.7 Cr	3	Maharashtra
BHARAT SERUMS AND VACCINES LIMITED	Amalgamated	9.0 Cr	2	Maharashtra
ZCL CHEMICALS LIMITED	Amalgamated	9.1 Cr	2	Maharashtra
RA CHEM PHARMA LIMITED	Amalgamated	8.5 Cr	3	Andhra Pradesh
BHARAT SERUMS AND VACCINES LIMITED	Active	73.1 L	2	Maharashtra
MANJUSHREE TECHNOPACK LIMITED	Active	13.7 Cr	2	Karnataka
MODENIK LIFESTYLE PRIVATE LIMITED	Active	34.4 Cr	1	Karnataka
NORTH STAR ASIA LLP	Active	50,000.0	1	Maharashtra
UNIVERSAL NUTRISCIENCE PRIVATE LIMITED	Active	230.9 Cr	1	Maharashtra
AKUMS DRUGS AND PHARMACEUTICALS LIMITED	Active	31.5 Cr	1	Delhi
INTELLECASH MICROFINANCE NETWORK COMPANY PRIVATE LIMITED	Amalgamated	11.2 Cr	1	Maharashtra
GUJARAT PIPAVAV PORT LIMITED	Active	483.4 Cr	1	Gujarat
PREMIUM MOTION PRIVATE LIMITED	Active	2.0 Cr	1	Maharashtra
PREMIUM TRANSMISSION PRIVATE LIMITED	Active	112.5 Cr	1	Maharashtra
CYIENT LIMITED	Active	55.5 Cr	1	Telangana
IDFC FIRST BANK LIMITED	Active	7,316.3 Cr	1	Tamil Nadu
INTELLECAP ADVISORY SERVICES PRIVATE LIMITED	Active	51.4 L	1	Maharashtra
GABRIEL INDIA LIMITED	Active	14.4 Cr	1	Maharashtra
GREENLAM INDUSTRIES LIMITED	Active	12.8 Cr	1	Delhi
EUREKA FORBES LIMITED	Active	193.5 Cr	1	Maharashtra
ZENSAR TECHNOLOGIES LIMITED	Active	45.3 Cr	1	Maharashtra
COMPUTER AGE MANAGEMENT SERVICES LIMITED	Active	49.2 Cr	1	Tamil Nadu
INDEGENE LIMITED	Active	47.9 Cr	1	Karnataka
AXIS FINANCE LIMITED	Active	627.1 Cr	1	Maharashtra
SOWPARNIKA RETAIL PRIVATE LIMITED	Active	1.0 L	1	Karnataka
GIL LIFESCIENCES PRIVATE LIMITED	Amalgamated	13.8 Cr	1	Telangana
INISPIRE HEALTHCARE SOLUTIONS PRIVATE LIMITED	Active	1.0 L	1	Telangana
CASPER PHARMA PRIVATE LIMITED	Active	26.1 Cr	1	Telangana
AVRA LABORATORIES PRIVATE LIMITED	Amalgamated	7.0 Cr	1	Maharashtra
KEIMED PRIVATE LIMITED	Active	6.8 Cr	1	Telangana
GOKALDAS INTIMATEWEAR PRIVATE LIMITED	Amalgamated	30.5 Cr	1	Karnataka
APOLLO HEALTHCO LIMITED	Active	2,884.9 Cr	1	Tamil Nadu
ADVENT INDIA PE ADVISORS PRIVATE LIMITED	Active	2.2 Cr	1	Maharashtra

Subsidiary Companies

Name	State / Country	Incorporation Year	Paidup Capital
SUVEN PHARMA INC	United States	-	-

Registered Details

CIN

L24299TG2018PLC128171

PAN

ABBCS1159F

Incorporation

2018, 6.5 years

Company Email

khrao@suvenpharm.com

Paid up Capital

₹ 25.5 Cr

Authorised Capital

₹ 40.0 Cr

AGM

Dec 2023

Type

Public

Non-government Company

FAQ - SUVEN PHARMACEUTICALS LIMITED

What is the incorporation date of SUVEN PHARMACEUTICALS LIMITED?

The incorporation date of SUVEN PHARMACEUTICALS LIMITED is 06 November, 2018

What is the authorized share capital of SUVEN PHARMACEUTICALS LIMITED?

The authorized share capital of SUVEN PHARMACEUTICALS LIMITED is INR ₹ 40.0 Cr.

What is the paid-up capital of SUVEN PHARMACEUTICALS LIMITED?

The paid-up capital of SUVEN PHARMACEUTICALS LIMITED is INR ₹ 25.5 Cr.

What is the registered address of SUVEN PHARMACEUTICALS LIMITED?

The registered address of SUVEN PHARMACEUTICALS LIMITED is # 8-2-334, SDE SERENE CHAMBERS, 3rd FLOOR AVENUE 7, ROAD NO. 5, BANJARA HILLS HYDERABAD Hyderabad Telangana - 500034

What is the CIN number of SUVEN PHARMACEUTICALS LIMITED?

The CIN number of SUVEN PHARMACEUTICALS LIMITED is L24299TG2018PLC128171.

Smart Suggestions

Uttar Pradesh
Haryana
Jammu & Kashmir
Punjab
Goa
Madhya Pradesh
Kerala
Gujarat
Andhra Pradesh
Telangana
Blog Categories
Top Blog post
Financial Resources

Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More

SUVEN PHARMACEUTICALS LIMITED

Leave site?

Buy Dashboard using Credits

Just a Quick Check!

Industry

Buy Report or Plans

Dashboards

Company dashboard

View subscriptions and buy credits

MCA Fillings

All financials

1 Year

PDF Reports

Financial report

Due diligence report

Locations

Locations on Map

Filter (4)

Select Tags

Choose Location

Tofler Score

Risk

About Tofler Score

Financial Highlights

Margins

Balance Sheet

Total assets

Profit & Loss

Revenue from operations

Ratios

Ratios

Charges on assets

Charges

People

Company Network